id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-280350-ay4cnzn5	Chan, Jasper F.W.	Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus	2013-10-03		.txt	text/plain	5166	168	34	73 Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic The emerging novel Middle East respiratory syndrome coronavirus: the knowns and unknowns Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia Middle East respiratory syndrome coronavirus (MERS-CoV); announcement of the coronavirus study group Global alert and response: Middle East respiratory syndrome coronavirus (MERS-CoV) e update e as of 4 October Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features Genetic relatedness of the novel human lineage C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5 Genetic characterization of Betacoronavirus lineage C viruses in bats revealed marked sequence divergence in the spike protein of Pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications on the origin of the novel Middle East Respiratory Syndrome Coronavirus Interspecies transmission and emergence of novel viruses: lessons from bats and birds Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe Coronaviruses in bats from Mexico Middle East respiratory syndrome coronavirus (MERS-CoV): challenges in identifying its source and controlling its spread Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications on disease pathogenesis and clinical manifestation Human coronavirus EMC does not require the SARScoronavirus receptor and maintains broad replicative capability in mammalian cell lines Middle East respiratory syndrome coronavirus neutralizing serum antibodies in dromedary camels: a comparative serological study Update: severe respiratory illness associated with middle East respiratory syndrome coronavirus (MERS-CoV) e Worldwide Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission Family cluster of middle East respiratory syndrome coronavirus infections Hospital outbreak of middle East respiratory syndrome coronavirus A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case First cases of middle East respiratory syndrome coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Identification of influenza A nucleoprotein as an antiviral target Two years after pandemic influenza A/2009/H1N1: what have we learned? Avian influenza A H5N1 virus: a continuous threat to humans Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome The emergence of influenza A (H7N9) sixteen years after influenza A(H5N1) in humans: a tale of two cities Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings Thiopurine analogues inhibit papain-like protease of severe acute respiratory syndrome coronavirus Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds Treatment of SARS with human interferons Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics Inhibition of novel b coronavirus replication by a combination of interferon-a2b and ribavirin Mycophenolate mofetil: an update Identification of active antiviral compounds against a New York isolate of West Nile virus Mycophenolic acid inhibits replication of Japanese encephalitis virus The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells Antiviral or proviral action of mycophenolic acid in hepatitis B infection?	cache/cord-280350-ay4cnzn5.txt	txt/cord-280350-ay4cnzn5.txt
